To the question of thrombotic and hemorrhagic complications in patients with COVID-19
N. I. Glushkov,
P. D. Puzdriak,
A. N. Zvyagintseva,
E. I. Panasyuk,
V. Yu. Gavrilov,
M. A. Ivanov,
K. V. Zhdanovich https://doi.org/10.18699/SSMJ20240416
Abstract
COVID-19 is characterized by various adverse consequences and complications, the prevention of which affects the outcome of the disease. Aim of the study was to investigate the thrombohemorrhagic events of COVID-19 infection. Material and methods. This study involved 403 patients with novel coronavirus infection; the patients were divided into 2 groups: 75 with COVID-19 complications and 328 patients without complications. Metabolic disorders, features of lung damage, comorbidity, signs of inflammation and coagulation, treatment outcomes, peculiarities of thrombotic events and hemorrhages development were studied. Results and its discussion. Thrombohemorrhagic complications of COVID-19 occurred mostly in patients with angina pectoris, coronary artery sclerosis and chronic heart failure of functional class II–III, as well as decompensated diabetes mellitus and obesity. These coronavirus infection effects are often accompanied by an increase in content of inflammatory markers such as CRP and ferritin, as well as of hypercoagulability (D-dimers). Conclusions. Manifestations of inflammatory coagulopathy in patients infected by COVID-19 increases risk of thrombohemorrhagic complications.
About the Authors
N. I. Glushkov
Northwestern State Medical University named after. I. I. Mechnikov of Minzdrav of Russia
Russian Federation
Russian Federation
Nikolay I. Glushkov, doctor of medical sciences, professor
195067, Saint-Petersburg, Piskarevsky ave., 47
P. D. Puzdriak
Northwestern State Medical University named after. I. I. Mechnikov of Minzdrav of Russia
Russian Federation
Russian Federation
Petr D. Puzdriak
195067, Saint-Petersburg, Piskarevsky ave., 47
A. N. Zvyagintseva
Northwestern State Medical University named after. I. I. Mechnikov of Minzdrav of Russia
Russian Federation
Russian Federation
Anastasia N. Zvyagintseva
195067, Saint-Petersburg, Piskarevsky ave., 47
E. I. Panasyuk
Northwestern State Medical University named after. I. I. Mechnikov of Minzdrav of Russia
Russian Federation
Russian Federation
Eleonora I. Panasyuk
195067, Saint-Petersburg, Piskarevsky ave., 47
V. Yu. Gavrilov
Northwestern State Medical University named after. I. I. Mechnikov of Minzdrav of Russia
Russian Federation
Russian Federation
Vladislav Yu. Gavrilov
195067, Saint-Petersburg, Piskarevsky ave., 47
M. A. Ivanov
Northwestern State Medical University named after. I. I. Mechnikov of Minzdrav of Russia
Russian Federation
Russian Federation
Mikhail A. Ivanov, doctor of medical sciences, professor
195067, Saint-Petersburg, Piskarevsky ave., 47
K. V. Zhdanovich
Northwestern State Medical University named after. I. I. Mechnikov of Minzdrav of Russia
Russian Federation
Russian Federation
Kristina V. Zhdanovich
195067, Saint-Petersburg, Piskarevsky ave., 47
References
1. Глушков Н.И., Иванов М.А., Апресян А.Ю., Пуздряк П.Д., Артемова А.С. Влияние метаболического синдрома на исходы реконструкций у больных с инфраингвинальной артериальной болезнью. Вестн. Сев.-Зап. гос. мед. ун-та им. И.И. Мечникова. 2018;10(3:):54–59. doi: 10.17816/mechnikov201810354-59
2. Лебедева А.А., Куликов А.Н., Ковальчук Ю.П., Кадинская М.И., Гинзбург А.М., Власов Т.Д. Эндотелиальная дисфункция и тромботические события у больных с тяжелым течением новой коронавирусной инфекции COVID-19. Учен. зап. Первого СПбГМУ. 2021;28(4):38–47. doi: 10.24884/1607-4181-2021-28-4-38-47
3. Макацария А.Д., Слуханчук Е.В., Бицадзе В.О., Хизроева Д.Х., Третьякова М.В., Шкода А.С., Элалами И., Ди Ренцо Д., Риццо Д., Пятигорская Н.В., … Митрюк Д.В. Влияние различных видов антикоагулянтной терапии на снижение летальности при COVID-19. Вестн. РАМН. 2021;76(3):268–278. doi: 10.15690/vramn1551
4. Временные рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 10 (08.02.2021). Режим доступа: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/054/588/original/Временные_МР_COVID-19_%28v.10%29-08.02.2021_%281%29.pdf.
5. Федотова Е.В., Чупров В.А., Чупрова А.А., Попов В.А., Хидиятов И.И., Авалиани В.М., Анкудинова И.С. Особенности тромбозов у пациентов с новой коронавирусной инфекцией COVID-19. Междунар. научно-исслед. ж. 2023;(1):127. doi: 10.23670/IRJ.2023.127.6
6. Коршунова А.А., Куликов А. Н., Трофимов В.И., Теплов В.М., Ковальчук Ю.П., Кадинская М.И., Гинзбург А.М., Лапин С.В. Прогнозирование тромботических и геморрагических событий у больных, госпитализированных с новой коронавирусной инфекцией COVID-19. Терапия. 2022;8(6):41–53. doi: 10.18565/therapy.2022.6.41-53
7. Darvall K.A., Sam R.C., Silverman S.H., Bradbury A.W., Adam D.J. Obesity and thrombosis. Eur. J. Vasc. Endovasc. Surg. 2007;33(2):223–233. doi: 10.1016/j.ejvs.2006.10.006
8. Hadi A.R., Carr C.S., Suwaidi J.A. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc. Health Risk Manage. 2005;1(3):183– 198.
9. Сумеркина В.А. Состояние системы гемостаза и маркеры дисфункции эндотелия у женщин с абдоминальным ожирением. Фундам. исслед. 2015;7(2):271–274.
10. Ohira T., Peacock J.M., Iso H., Chambless L.E., Rosamond W.D., Folsom A.R. Serum and dietary magnesium and of ischemic stroke: the Atherosclerosis Risk in Communities Study. Am. J. Epidemiol. 2009;169(12):1437–1444. doi: 10.1093/aje/kwp071
11. Carr M.E. Diabetes mellitus: a hypercoagulable state. J. Diabetes Complicat. 2001;15(1):44–54. doi: 10.1016/s1056-8727(00)00132-x
12. Bellosta R., Luzzani L., Natalini G., Pegorer M.A., Attisani L., Cossu L.G., Ferrandina C., Fossati A., Conti E., Bush R. L., Piffaretti G. Acute limb ischemia in patients with COVID-19 pneumonia. J. Vasc. Surg. 2020;72(6):864–1872. doi: 10.1016/j.jvs.2020.04.483
13. Harari R., Bangalore S., Chang E., Shah B. COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock. Catheter. Cardiovasc. Interv. 2021;97(5):E661–E666. doi: 10.1002/ccd.28992
14. Gulsen A., Yigitbas B.A., Uslu B., Drömann D., KilincO. The effect of smoking on COVID-19 symptom severity: systematic review and meta-analysis. Pulm. Med. 2020;2020:7590207. doi: 10.1155/2020/7590207
15. Piché M.E., Lemieux S., Weisnagel S.J., Corneau L., Nadeau A., Bergeron J. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am. J. Cardiol. 2005;96(1):92–97. doi: 10.1016/j.amjcard.2005.02.051
16. Favaloro E.J., Franchini M., Lippi G. Aging hemostasis: changes to laboratory markers of hemostasis as we age - narrative review. Semin. Thromb. Hemost. 2014;40(6):621–633. doi: 10.1055/s-0034-1384631
Review
Views:
694
Email this article 